Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Nov 4 - Nov 9
Chronic exposure data in any species is insufficient to draw conclusions about carcinogenicity, organ toxicity, or endocrine disruption from prolonged BPC-157 administration
In the SURPASS-2 study, tirzepatide 15 mg resulted in a faster and greater decline in body weight ( 5.5 kg) compared to semaglutide 1.0 mg, more than doubling the proportion of patients achieving at least 10% weight loss (57% vs 24%) [3]
Why site rotation matters Injecting in the same spot repeatedly causes lipohypertrophy, which is a buildup of fatty tissue under the skin at the injection site
One point is where it seems to act
Nitric Oxide Modulation: Research has observed that BPC-157 may indirectly affect nitric oxide (NO) signaling, a key regulator of vascular tone and inflammation
US$ 29.36
US$ 23.69
US$ 23.59
US$ 20.68
